期刊文献+

成人尸体原位肝移植的远期死亡原因和危险因素分析 被引量:1

ANALYSIS OF THE CAUSES AND RISK FACTORS OF LATE MORTALITY IN ORTHOTOPIC LIVER TRANSPLANTATION IN ADULTS
下载PDF
导出
摘要 目的成人尸体原位肝移植术后六月内死亡的常见原因是感染或者移植物衰竭,然而远期并发症导致死亡的原因尚未完全明朗。本研究目的是分析远期死亡的常见原因以及导致死亡的危险因素。方法 1991年10月-2003年4月间在香港大学玛丽医院为107例成人终末期肝病患者施行了112次尸体原位肝移植,对术后存活超过半年的远期死亡患者进行了分析(平均随访时间2.6年,范围0.5-11.2年);对供体、受体和手术等变量采用单变量(Cox回归)分析方法筛选肝移植术后远期死亡相关的危险因素。结果在研究期间112次移植共有34个移植物丧失(30.4%),其中有16个移植物在存活半年后丧失(14.3%)。总的1年、5年和10年移植物存活率分别是86.6%、73.3%和50.7%。远期死亡原因主要是感染(50%),器官功能衰竭(12.5%)。单变量分析法未能确定有意义的死亡危险因素。结论感染和器官功能衰竭是成人尸体原位肝移植远期死亡的主要原因,其远期死亡相关的危险因素尚不能确定。 Objective The most common causes of death within six months after orthotopic liver transplantation (OLTx)in adults are infection or graft failure. However,the causes leading to recipient death in the late stage after OLTx are still not to be elucidated. In this study,the most common causes and risk factors associated with late mortality after OLTx wre identified. Methods A total of 112 OLTx were performed in 107 adult patients with end-stage liver disease in the University of Hongkong Medical Centre between October 1991 and April 2003. All the patients died six months after OLTx were reviewed (mean follow-up 2.6 years,range 0.5~11.2). Perioperative variables were analyzed using univariate techniques (cox regression)to indentify risk factors. Result 34 allografts (30. 4%) were lost in 112 OLTx during the study period. 16 allografts(14.3% ) were lost in the recipients who survived more than six months. The overall graft survival rates at 1 year,5 years and 10 years were 86. 6%, 73. 3% and 50. 7%,respectively. The main causes of late death were infection (50%) and organ failure(12.5%). No perioperative variables were identified as risk factore for late death using univariate techniques in our single center. Conclusion Infection and organ failure were the major causes of late death among adult OLTx recipients. The risk factors associated with late mortality are not identified yet.
出处 《肝胆外科杂志》 2006年第1期19-22,共4页 Journal of Hepatobiliary Surgery
关键词 肝移植 远期死亡 危险因素 Liver transplantation Late mortality Risk factor
  • 相关文献

参考文献10

  • 1Kaur S,Cotler S.Advances in liver transplantation:overivew and status[J].Dis Month,1999,45:150-183.
  • 2Roberts MS,Angus DC,Bryce CL,et al.Survival after liver transplantation in the United States:a disease-specific analysis of the UNOS database[J].Liver transpl,2004,10 (7):886-897.
  • 3Cuervas-Mons V,Julio Martinez A,Dekker A,et al.Adult liver transplantation:an analysis of the early causes of death in 40consecutive cases[J].Hepatology,1986,6:495-501.
  • 4Asfar S,Metrakos P,Fryer J,et al.An anlysis of late deaths after liver transplantation[J].Transplantation,1996,61 :1377-1381.
  • 5Rabkin JM,La Melena V,Orloff SL,et al.Late mortality after orthotopic liver transplantation[J].Am J Surg,2001,181:475-479.
  • 6Neuberger J.Liver Transplantation[J].J Hepatol,2000,32:198-207.
  • 7Sudan DL,Venkataramani A,Lynch J,et al.Causes of late mortality in survivors of liver transplantation[J].Transplantat ion,1999,67:S564.
  • 8Asfar S,Metrakos P,Fryer J,et al.An analysis of late deaths after liver transplantation[J].Transplantation.1996,61:1377-1381.
  • 9Yokohama I,Takagi H:Liver transplantation and hepatocellular carcinoma[J].Sem Surg Oncol,1996,12:212-216.
  • 10Moreno Planas JM,Rubio Gonzalez E,Herreros de Tejada A,et al.Late mortality in patients with liver transplantation:causes and risk factors[J].Transplant proc,2003,35:707-708.

同被引文献12

  • 1郑树森,徐骁,梁廷波,陈海勇,王伟林,吴健.肝移植术后早期肝动脉血供不良与胆道并发症[J].中华医学杂志,2005,85(24):1665-1669. 被引量:24
  • 2陈规划.加强术后中长期管理,改善和提高我国肝移植受者的长期生存质量[J].中华肝胆外科杂志,2006,12(5):289-291. 被引量:9
  • 3董家鸿,张雷达,王曙光,别平,杨占宇.肝移植术后缺血型胆道病变的预防和治疗[J].中华医学杂志,2006,86(18):1236-1239. 被引量:29
  • 4易述红,陈规划,陆敏强,杨扬,蔡常洁,许赤,李华,汪根树,易慧敏.原位肝移植术后侵袭性曲菌病的诊断和治疗[J].中华外科杂志,2006,44(13):885-888. 被引量:9
  • 5MatsuoK, Sekido H, Morioka D, et al. Surveillance of perioperative infections after adult living donor liver transplantation. Transplant Proc, 2004, 36 : 2299-2301.
  • 6Rizzeffo M, Recchia S, Salizzoni M. Liver transplantation in carriers of the HbsAg. J Hepatol, 1991, 13:5-7.
  • 7SeehoferD, Raues N, Steinmuller T, et al. Combination prophylaxis with hepatitis B immunoglobulin and Lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant Lamivudine resistance. Z Gastroenterol, 2002, 40:795-799.
  • 8Han SH, Martin P, Edelstein M, et al. Conversion from intravenous to intramuscular hepatitis B immunoglobulin in combination with Lamivudine is safe and Cost effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation. Liver Transpl, 2003, 9:182-187.
  • 9Mills JM. Treatment of liver allograft rejection. Liver Transplant Surg, 1999, 5Suppl:98-106.
  • 10Navasa M, Bustamante M, Marroni C, et al. Diabetes mellitus after Liver transplantation: prevalence and predictive factors. J Hepatol, 1996, 25: 64271.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部